CLSK

Value Q1, 25Q2, 26Q3, 26 TTM Total revenue 223 K-3.99 M-2.92 M -7.19 M Gross profit -95.4 M-85.68 M-88.41 M -367.24 M Operating expenses 402.11 M400.4 M132.26 M 1.06 B Selling/general/admin expenses 15.44 M16.11 M18.3 M 64.11 M Research & development ——— — Operating income -316.55 M-345.68 M-232.4 M -893.8 M Non-Operating Income, Total ——318 K — Interest expense, net of interest capitalized 3.93 M1.95 M2.04 M 12.98 M Non-Operating Income, excl. Interest Expenses ——-2.04 M — Unusual income/expense ——318 K — Pretax income -378.71 M-378.34 M-234.12 M -587.6 M Equity in earnings ——— — Taxes 31.41 M9.89 M2.97 M 53.02 M Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -378.71 M-378.34 M-239.84 M -997.82 M Discontinued operations ——— — Net income -378.71 M-378.34 M-239.84 M -997.82 M Dilution adjustment 000 0 Preferred dividends 030 M0 30.4 M Diluted net income available to common stockholders -378.71 M-408.34 M-239.84 M -1.03 B Basic earnings per share (Basic EPS) -1.35-1.52— — Diluted earnings per share (Diluted EPS) -1.35-1.52-0.89 -3.77 Average basic shares outstanding 281.47 M267.83 M268.43 M — Diluted shares outstanding 281.47 M267.83 M268.43 M — EBITDA -391.2 M-370.2 M-262.29 M -1.14 B EBIT -497.51 M-486.08 M-373.33 M -1.58 B Cost of revenue 95.62 M81.69 M85.48 M 360.05 M Other cost of goods sold ——— — Depreciation & amortization (cash flow) 106.31 M115.88 M111.04 M 441.55 M